Practice
Featured experience
Quanta Computer strategic collaboration with and investment in Rigetti
We are advising Quanta on the transaction
Avianca senior secured notes offering and exchange offer and consent solicitation
The transactions included a $1 billion senior secured notes offering and a $1.1 billion exchange offer and consent solicitation
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Spirit Airlines prearranged chapter 11 filing
We are advising Spirit Airlines in connection with entry into an RSA and negotiation of a prearranged chapter 11 plan
VF spinoff of Kontoor Brands
Davis Polk advised V.F. Corporation in connection with the spinoff of its wholly owned subsidiary, Kontoor Brands, Inc.,…
Natura acquisition of Avon
Davis Polk is advising Natura Cosméticos S.A. on its all-share acquisition of Avon Products, Inc. The transaction, which is…
Davis Polk Advises Comcast on Its Acquisition of Deep Blue Communications
Davis Polk advised Comcast Corporation in connection with its acquisition of Deep Blue Communications, LLC. Financial terms…
Fastly, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $207 million initial public offering…
Applied Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $40 million initial public offering…
Comcast agreement with Disney on Hulu’s future governance and ownership
Davis Polk is advising Comcast Corporation on its “put/call” agreement with The Walt Disney Company regarding NBCUniversal’s…
Uber Technologies $8.1 billion IPO
Davis Polk advised the underwriters in connection with the $8.1 billion initial public offering of 180,000,000 shares of…
NGM Biopharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 7,521,394 shares of common stock of NGM…
TransMedics Group, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of…
Turning Point Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $191.5 million initial public…